PubMed HealthSearch

SEARCH · PubMed Health

Results for “Dermatological Effects”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Cosmetics, the consumer, the factory worker and the occupational physician. Suggestions concerning ways to determine untoward dermatologic effects of cosmetics.

Methods for investigating contact eczematous patients and for measuring the sensitizing potential of various substances are well known and in general, sufficiently effective. This is not true for irritant dermatitis, or for possible (skin) irritant substances; moreover, cosmetics commonly do not contain acutely harmful ingredients. The use of various instrumental measurements (insensible H2O loss, CO2 release, electrical impedance, sweat rate) as indicators of the irritant potentials of substances is advocated. At the same time it is suggested that the factory physician actively investigate the workers in his factory, since these workers are exposed to known substances in known concentrations and combinations, possibly for extensive periods. This may prove to be part of a new role for him. A cosmetic may be one of several factors increasing impairment and only beyond a certain limit may this result in overt disease. Below that limit the health reserve is only partially depleted. Whether this is harmful to a person depends on other stresses, such as medicaments, work materials, other cosmetics and environmental chemicals. The effect of these must also be quantified. A model of these cumulative stresses and reactions is presented and discussed.

Cosmetics

Crack hands: a dermatologic effect of smoking crack cocaine.

We have seen multiple cases of a characteristic skin lesion produced by smoking crack cocaine. We describe a typical case with photographs demonstrating multiple blackened hyperkeratotic lesions of the palmar aspects of the fingers and palm, some linear, some circular. These involve mostly the dominant hand and are caused by the heat of the glass cocaine pipe.

Adult

[Dermatologic effects of two facial prosthesis materials in combination with glues].

Erythema is frequently observed in the region of contact between facial prostheses and the skin. In a large-scale study on the cutaneous tolerance of facial prosthesis materials, two prosthetic materials (glue and the solvent for the glue) were tested in the allergy test after Magnusson and Kligman (OECD). Only the solvent showed a moderately pronounced allergenic potential in the macroscopic assessment.

Adhesives

Comparison of muscle-derived serum carbonic anhydrase III and myoglobin in dermatological patients: effects of isotretinoin treatment.

The serum levels of muscle-specific serum carbonic anhydrase III (S-CAIII) and myoglobin (S-Myo) were analyzed in various male dermatological patients of the same age. The mean levels of S-CAIII and S-Myo were essentially similar in patients with acne, psoriasis vulgaris, atopic eczema and tinea, suggesting that common dermatological diseases do not affect the serum levels of the muscle markers. Increased levels of S-CAIII, which is specific for skeletal muscle cells, were found in the acne patients who had been treated with isotretinoin. However, when S-CAIII and S-Myo were studied in 24 patients (16 males, 8 females) before and during isotretinoin treatment, no constant increases in these markers could be observed. When individual patients were followed for several months, transient increases or decreases could be observed. The changes in S-CAIII, or S-Myo, did not correlate with the dose of isotretinoin, nor with the duration of the treatment. The results suggest that systemic isotretinoin does not specifically affect skeletal or myocardial muscles. The increases in these markers observed in the course of dermatological diseases and isotretinoin treatment are obviously due to other factors, such as exercise.

Adolescent

[Oxatomide: review of pharmacodynamic effects and clinical effects in dermatology].

Oxatomide is a new anti-allergy drug, derived from benzamidazole, which has shown original pharmacological properties at different stages of the degranulation of mastocytes and basophils, inhibition of the increase of intracellular calcium, inhibition of histamine release and of the synthesis of leukotrienes and prostaglandins. In addition, it has an antagonistic action on the histamine H1 receptors and inhibits the effects of serotonin and SRSA leukotrienes. Clinical trials have shown the clinical efficacy of oxatomide on chronic urticaria and atopic dermatitis, double blind against placebo. Also its action is quicker than certain reference molecules with which it was compared. The product seems to have excellent tolerance. Oxatomide is a molecule of which the pharmacological properties are coupled with clinical efficacy on allergic dermatoses.

Animals

Effective topical dermatologic therapy.

Experienced dermatologists regularly use a great variety of topical dermatologic mixtures. Extemporaneously prepared medications are of great value in the treatment of those problems that fail to respond to the usually therapeutic commercially available products. These mixtures are also desirable in treating individuals in whom corticosteroid preparations were initially beneficial but were of less value with continued application. This article presents an accumulation of a quarter century of practical extemporaneously compounded dermatologic preparations.

Administration, Topical

[Dermatologic manifestation of undesirable effects of drugs (excluding cytostatic drugs)].

Medications, consumed more and more frequently as a result of self-medication or prescribed under medical supervision, have multiple side effects, including dermatological ones. In fact, the latter represent the primary cause of drug intolerance. However, the diagnosis is not always made easily and is based upon standardized norms defined by pharmacology control centers. Fixed pigmented eruptions are the only erythema solely of drug-induced origin. Failure to recognize a drug-induced dermatological manifestation can be fatal if the drug is taken again, as in the case of toxic epidermal necrolysis.

Autoimmune Diseases